Perflexane

CHEMBL1200607 Phase 4 Approved Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
338.0 g/mol
LogP
5.1
Phase
4

A perfluorocarbon liquid investigated as a blood substitute and oxygen carrier, and also studied as an ultrasound contrast agent. Its ability to dissolve large amounts of oxygen makes it a candidate for treating ischemia and enhancing tumor oxygenation during radiation therapy.

Molecular Weight

338.0400 g/mol

LogP

5.10

TPSA

0.00 Ų

Lipinski RO5

Fail

Therapeutic Areas

Mechanism of Action

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mechanism

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

2D Structure

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F

InChI

InChI=1S/C6F14/c7-1(8,3(11,12)5(15,16)17)2(9,10)4(13,14)6(18,19)20

Molecular Formula

C6F14

HBD / HBA

- / 14

Rotatable Bonds

3

Heavy Atoms

20

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

A perfluorocarbon liquid investigated as a blood substitute and oxygen carrier, and also studied as an ultrasound contrast agent. Its ability to dissolve large amounts of oxygen makes it a candidate for treating ischemia and enhancing tumor oxygenation during radiation therapy.

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

Yes, Perflexane is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200607. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 9639. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.